Literature DB >> 11141130

The renaissance of C reactive protein.

M B Pepys, A Berger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11141130      PMCID： PMC1119308          DOI： 10.1136/bmj.322.7277.4

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

1.  Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

Authors:  F Haverkate; S G Thompson; S D Pyke; J R Gallimore; M B Pepys
Journal:  Lancet       Date:  1997-02-15       Impact factor: 79.321

2.  Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses.

Authors:  J Danesh; P Whincup; M Walker; L Lennon; A Thomson; P Appleby; J R Gallimore; M B Pepys
Journal:  BMJ       Date:  2000-07-22

3.  C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

Authors:  J S Yudkin; C D Stehouwer; J J Emeis; S W Coppack
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-04       Impact factor: 8.311

4.  Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty.

Authors:  A Buffon; G Liuzzo; L M Biasucci; P Pasqualetti; V Ramazzotti; A G Rebuzzi; F Crea; A Maseri
Journal:  J Am Coll Cardiol       Date:  1999-11-01       Impact factor: 24.094

5.  Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation.

Authors:  S Bhakdi; M Torzewski; M Klouche; M Hemmes
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-10       Impact factor: 8.311

6.  Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators.

Authors:  P M Ridker; N Rifai; M A Pfeffer; F Sacks; E Braunwald
Journal:  Circulation       Date:  1999-07-20       Impact factor: 29.690

7.  Coronary C-reactive protein distribution: its relation to development of atherosclerosis.

Authors:  Y X Zhang; W J Cliff; G I Schoefl; G Higgins
Journal:  Atherosclerosis       Date:  1999-08       Impact factor: 5.162

8.  C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor.

Authors:  J Cermak; N S Key; R R Bach; J Balla; H S Jacob; G M Vercellotti
Journal:  Blood       Date:  1993-07-15       Impact factor: 22.113

9.  The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina.

Authors:  G Liuzzo; L M Biasucci; J R Gallimore; R L Grillo; A G Rebuzzi; M B Pepys; A Maseri
Journal:  N Engl J Med       Date:  1994-08-18       Impact factor: 91.245

10.  C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction.

Authors:  M Griselli; J Herbert; W L Hutchinson; K M Taylor; M Sohail; T Krausz; M B Pepys
Journal:  J Exp Med       Date:  1999-12-20       Impact factor: 14.307
View more
  12 in total

1.  C reactive protein and acute phase of ischaemic stroke.

Authors:  M Di Napoli
Journal:  BMJ       Date:  2001-06-30

2.  Urinalysis for interleukin-8 in the non-invasive diagnosis of acute and chronic inflammatory diseases.

Authors:  A S Taha; V Grant; R W Kelly
Journal:  Postgrad Med J       Date:  2003-03       Impact factor: 2.401

3.  High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potential.

Authors:  Lambert Busque; Maxine Sun; Manuel Buscarlet; Sami Ayachi; Yassamin Feroz Zada; Sylvie Provost; Vincent Bourgoin; Luigina Mollica; Marlies Meisel; Reinhard Hinterleitner; Bana Jabri; Marie-Pierre Dubé; Jean-Claude Tardif
Journal:  Blood Adv       Date:  2020-06-09

Review 4.  Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.

Authors:  David Williams; John Feely
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

5.  The importance of determining procalcitonin and C reactive protein in different stages of sepsis.

Authors:  Zana Baruti Gafurri; Hidajet Pacarizi; Bukurije Zhubi; Luljeta Begolli; Valdete Topciu
Journal:  Bosn J Basic Med Sci       Date:  2010-02       Impact factor: 3.363

6.  A Study of Association of Ankle Brachial Index (ABI) and the Highly Sensitive C - Reactive Protein (hsCRP) in Type 2 Diabetic Patients and in Normal Subjects.

Authors:  Thejaswini K O; Roopakala M S; Dayananda G; Chandrakala S P; Prasanna Kumar K M
Journal:  J Clin Diagn Res       Date:  2012-10-14

7.  C-reactive protein used as an early indicator of infection in patients with systemic inflammatory response syndrome.

Authors:  Rafael Sierra; Jordi Rello; María Angeles Bailén; Encarnación Benítez; Antonio Gordillo; Cristobal León; Sebastián Pedraza
Journal:  Intensive Care Med       Date:  2004-09-11       Impact factor: 17.440

8.  Historical Loss: Implications for Health of American Indians in the Blackfeet Community.

Authors:  Neha A John-Henderson; Benjamin Oosterhoff; Taylor D Kampf; Brad Hall; Lester R Johnson; Mary Ellen Laframboise; Melveena Malatare; Emily Salois; Jason R Carter; Alexandra K Adams
Journal:  Ann Behav Med       Date:  2022-02-11

9.  Effects of disease modifying agents and dietary intervention on insulin resistance and dyslipidemia in inflammatory arthritis: a pilot study.

Authors:  Patrick H Dessein; Barry I Joffe; Anne E Stanwix
Journal:  Arthritis Res       Date:  2002-09-16

10.  C-reactive protein and lipid profiles in Korean patients with normal tension glaucoma.

Authors:  Jaewan Choi; Soo Geun Joe; Mincheol Seong; Jin Young Choi; Kyung Rim Sung; Michael S Kook
Journal:  Korean J Ophthalmol       Date:  2009-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.